Acutaas Chemicals Limited — Investor Meet, 24-10-2025: Analysts/Institutional Investor Meet/Con. Call Updates

Acutaas Chemicals reported strong Q2 FY26 results: Revenue up 24.1% YoY to 306.2 Cr, EBITDA jumped nearly 2x to 95.3 Cr (31.1% margin), and PAT surged 91.3% to 71.9 Cr. Management is confident of ~25% FY26 revenue growth and revised sustainable EBITDA margins of 28-30%, driven by CDMO and strategic product mix. New battery chemical production starts Q4 FY26, with a Korea JV contributing H2 FY27. Cash from operations was 136.5 Cr in H1, supporting 250 Cr FY26 capex. The diversified strategy aims for sustained long-term growth.